Home›Quality Guide

About Pharma Quality System

About Pharma Quality System

Practical pharmaceutical quality knowledge for real-world work.

Pharma Quality System publishes clear, practical educational guides on GMP, Quality Assurance, Quality Control, pharmaceutical quality systems, laboratory work, regulatory concepts, and pharma career development.

Last updated: August 23, 2026

Our Purpose

Pharmaceutical quality can be difficult to learn because many topics sit between regulations, company procedures, scientific principles, laboratory practice, and day-to-day industry work. Our goal is to make those topics easier to understand without oversimplifying them.

We focus on content that helps readers understand not only what a pharmaceutical quality concept means, but also how it is applied in practice, why it matters, and how it connects to other parts of the Pharmaceutical Quality System. For regulatory topics, U.S. FDA and Health Canada context is emphasized when relevant, with ICH, USP, WHO, and EU GMP used where they add appropriate technical or international context.

What We Cover

GMP & cGMP Good Manufacturing Practice, documentation, compliance, facilities, equipment, materials, production, and quality systems.
Quality Assurance CAPA, deviations, change control, investigations, audits, risk management, batch review, and quality oversight.
Quality Control Laboratory testing, specifications, HPLC, analytical work, OOS/OOT concepts, stability, and laboratory quality practices.
ICH & Regulatory Quality Guidelines and quality concepts from organizations such as FDA, Health Canada, ICH, USP, WHO, and EU GMP when relevant to the topic.
Pharma Careers Role comparisons, practical skills, interview preparation, career paths, and guidance for entering pharmaceutical quality functions.

Who This Site Is For

Our content is designed for:

  • Pharmacy, chemistry, biotechnology, and life-science students exploring pharmaceutical careers.
  • Entry-level professionals preparing for QA, QC, production, validation, or regulatory roles.
  • Pharmaceutical employees who want a clearer understanding of quality-system concepts.
  • Job candidates preparing for technical and quality-focused interviews.
  • Readers looking for structured explanations supported by credible regulatory and technical sources.

How We Build Our Guides

We aim to make each guide useful beyond a basic definition. Depending on the topic, our articles may include:

  • Practical pharmaceutical examples and realistic scenarios.
  • Comparison tables and step-by-step workflows.
  • Original diagrams, infographics, and visual explanations.
  • Career and interview relevance where appropriate.
  • Internal links that connect related GMP, QA, QC, and career topics.
  • References to authoritative sources such as FDA, Health Canada, ICH, USP, WHO, and EU GMP when applicable.
Our editorial approach: We prioritize clarity, practical value, transparent sourcing, and content written for real readers-not keyword stuffing or publishing large volumes of shallow articles.

Our Source Standards

Pharmaceutical requirements can vary by jurisdiction, product type, dosage form, company procedure, and regulated activity. When a topic involves regulatory or quality-system requirements, we prefer primary and authoritative sources whenever possible.

These may include the U.S. Food and Drug Administration (FDA), Health Canada, the International Council for Harmonisation (ICH), the United States Pharmacopeia (USP), the World Health Organization (WHO), and European Union GMP guidance.

References are included within relevant articles so readers can review the original source material directly.

Editorial Team and Review Process

Content is developed under the Pharma Quality System Editorial Team using an evidence-led process that prioritizes authoritative sources, practical usefulness, clear distinctions between regulatory requirements and industry practice, and post-publication corrections when needed.

For more detail about sourcing, review, corrections, independence, and use of digital tools, see our Editorial Policy.

Educational Scope

Pharma Quality System is an educational and career-development resource. Our content is intended to explain pharmaceutical quality concepts and professional practices in an accessible way.

The information on this site does not replace applicable laws, regulations, current official guidance, approved company procedures, professional judgment, or site-specific training.

Start Exploring

Pharma Quality System
Practical pharmaceutical quality education for students, job candidates, and industry professionals.

Comments

Post a Comment

Popular posts from this blog

OOS in Pharmaceutical Industry: Investigation, Phase I & II, Examples

Image
Published by: Pharma Quality System Editorial Team • Editorial basis: FDA OOS guidance  (2022) ,  21 CFR 211.192,  Health Canada GUI-0001, and current GMP quality-system principles Pharmaceutical Quality Control & Laboratory Investigations An Out-of-Specification (OOS) result is not simply a failed number to retest until it passes. It is a quality signal that requires a scientifically sound, documented investigation to determine whether the result reflects laboratory error, manufacturing variability, material failure, or another assignable cause. Quick answer In pharmaceutical testing, OOS means a test result falls outside an established specification or acceptance criterion. FDA expects the result to be investigated rather than ignored or averaged away. The investigation generally begins with a focused laboratory assessment and expands to a full-scale investigation when a conclusive lab...
Read more

Health Canada GMP Guidelines (GUI-0001): Requirements, Inspections & Drug Establishment Licences

Image
  Published by: Pharma Quality System Editorial Team • Editorial basis: Health Canada GUI-0001, GUI-0002, GMP inspection, Drug Establishment Licence and risk-classification guidance CANADA GMP • GUI-0001 • DEL • INSPECTIONS Health Canada's GMP framework is built around Part C, Division 2 of the Food and Drug Regulations. GUI-0001 explains how regulated establishments should meet those GMP expectations, while Drug Establishment Licence requirements under Division 1A determine which Canadian activities may legally be conducted. Quick answer GUI-0001 is Health Canada's main GMP guide for drug products. It interprets GMP requirements in Part C, Division 2 of the Food and Drug Regulations and is used by Health Canada during inspections. Canadian establishments that fabricate, package/label, distribute, import, wholesale or test drugs generally need a valid Drug Establishment Licence (DEL) for ...
Read more

Data Integrity in Pharmaceutical Industry: ALCOA+ Principles, FDA Guidance & Examples

Image
  Published by:   Pharma Quality System Editorial Team   • Editorial basis: FDA data-integrity guidance (2018), Health Canada GUI-0001 and GUI-0050, WHO pharmaceutical data-integrity principles and 21 CFR Part 11 Last reviewed: September 4, 2026 GMP • QUALITY SYSTEMS • LABORATORY & MANUFACTURING DATA Pharmaceutical decisions are only as reliable as the data behind them. Data integrity means that records remain complete, consistent, accurate, attributable, and trustworthy throughout their lifecycle—from the moment data are generated until they are reviewed, reported, retained, and retrieved. Quick answer In the pharmaceutical industry, data integrity is the assurance that data are reliable and remain trustworthy throughout their lifecycle. WHO describes the expected characteristics using ALCOA+ : Attributable, Legible, Contemporaneous, Original or a true copy, Accurate, Complete, Consistent, Enduring, and Available. FDA expects firms to use meani...
Read more